Comment on: “Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial”-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comment on: “Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: The Bio-K multicenter trial”

Published:2024-07 Issue: Volume:337 Page:115987
ISSN:0165-1781
Container-title:Psychiatry Research
language:en
Short-container-title:Psychiatry Research

Author:

Kwaśna Julia^ORCID,Kwaśny Aleksander,Bychowski Mateusz,Kwaśna Magdalena,Pastuszak Michał

Publisher

Elsevier BV

Reference5 articles.

1. Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD);Fava;Mol. Psychiatry,2020

2. Does body mass index predict response to intravenous ketamine treatment in adults with major depressive and bipolar disorder? Results from the Canadian rapid treatment center of excellence;Lipsitz;CNS Spectr.,2022

3. The effectiveness of repeated intravenous ketamine on depressive symptoms, suicidal ideation and functional disability in adults with major depressive disorder and bipolar disorder: results from the Canadian Rapid Treatment Center of Excellence;McIntyre;J. Affect. Disord.,2020

4. A consensus statement on the use of ketamine in the treatment of mood disorders;Sanacora;JAMA Psychiatry,2017

5. Change in neurocognitive functioning in patients with treatment-resistant depression with serial intravenous ketamine infusions: the Bio-K multicenter trial;Singh;Psychiatry Res.,2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3